Jones James bought CPIX
June 23, 2025 · Form 4 insider transaction
Jones James bought 8 shares of Cumberland Pharmaceuticals Inc. at $4.61 per share, a transaction worth $36.88. The trade was recorded as open-market purchase under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 18 days after the transaction.
Direction
Acquired (buy-side)
Shares
8
Price
$4.61
Total value
$36.88
InsiderJones James
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateJune 23, 2025
Filing dateJuly 11, 2025
Shares owned after43,288
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024.